Therefore, it is not surprising that an epigenetic reprogramming is described in CD8+ T cells from CLL patients, which is associated with an inverted CD4/CD8 ratio and a poor outcome [53]. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.